Information
-
Trademark
-
90059153
-
Serial Number
90059153
-
Registration Number
7340237
-
International Classifications
-
Filing Date
July 17, 2020
4 years ago
-
Registration Date
March 26, 2024
10 months ago
-
Transaction Date
August 29, 2024
5 months ago
-
Status Date
March 26, 2024
10 months ago
-
Published for Opposition Date
January 05, 2021
4 years ago
-
Location Date
February 20, 2024
12 months ago
-
First Use Anywhere Date
October 02, 2023
a year ago
-
First Use In Commerce Date
October 02, 2023
a year ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
CHISOLM, KEVON
-
Attorney Docket Number
130197-90501
Attorney Name
Keith Toms, Esq.
Law Office Assigned Location Code
L30
-
Owners
Mark Drawing Code
3
Mark Identification
LARIMAR THERAPEUTICS
Case File Statements
- DM0000: The mark consists of the stylized word "Larimar" in black with a blue letter "i" above the word "Therapeutics" in black; extending from the dot of the letter is s a curled ribbon in the colors blue, teal, and white; the remaining color white represents a transparent background which is not a feature of the mark.
- GS0051: Pharmaceutical preparations for the treatment of mitochondrial disorders; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy
- CC0000: The color(s) black, white, blue and teal is/are claimed as a feature of the mark.
- DS0000: "THERAPEUTICS"
- GS0421: Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases
Case File Event Statements
-
7/21/2020 - 4 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
8/7/2020 - 4 years ago
2 - TEAS VOLUNTARY AMENDMENT RECEIVED
Type: PARI
-
8/7/2020 - 4 years ago
3 - TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Type: TAEA
-
8/14/2020 - 4 years ago
4 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
8/15/2020 - 4 years ago
5 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
10/29/2020 - 4 years ago
6 - ASSIGNED TO EXAMINER
Type: DOCK
-
11/6/2020 - 4 years ago
7 - PRIORITY ACTION WRITTEN
Type: CPRA
-
11/6/2020 - 4 years ago
8 - PRIORITY ACTION E-MAILED
Type: GPRA
-
11/6/2020 - 4 years ago
9 - NOTIFICATION OF PRIORITY ACTION E-MAILED
Type: GPRN
-
11/30/2020 - 4 years ago
10 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
11/30/2020 - 4 years ago
11 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
11/30/2020 - 4 years ago
12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
11/30/2020 - 4 years ago
13 - ASSIGNED TO LIE
Type: ALIE
-
11/30/2020 - 4 years ago
14 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
12/1/2020 - 4 years ago
15 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
12/16/2020 - 4 years ago
16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
1/5/2021 - 4 years ago
17 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
1/5/2021 - 4 years ago
18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
3/2/2021 - 3 years ago
19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
6/16/2021 - 3 years ago
20 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Type: ASGN
-
9/1/2021 - 3 years ago
21 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
9/1/2021 - 3 years ago
22 - SOU EXTENSION 1 FILED
Type: EXT1
-
9/1/2021 - 3 years ago
23 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
9/3/2021 - 3 years ago
24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
2/25/2022 - 2 years ago
25 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
2/25/2022 - 2 years ago
26 - SOU EXTENSION 2 FILED
Type: EXT2
-
2/25/2022 - 2 years ago
27 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
3/1/2022 - 2 years ago
28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
9/1/2022 - 2 years ago
29 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
9/1/2022 - 2 years ago
30 - SOU EXTENSION 3 FILED
Type: EXT3
-
9/1/2022 - 2 years ago
31 - SOU EXTENSION 3 GRANTED
Type: EX3G
-
9/3/2022 - 2 years ago
32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
2/28/2023 - a year ago
33 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
2/28/2023 - a year ago
35 - SOU EXTENSION 4 FILED
Type: EXT4
-
3/13/2023 - a year ago
34 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
3/14/2023 - a year ago
36 - SOU EXTENSION 4 GRANTED
Type: EX4G
-
3/15/2023 - a year ago
37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
9/1/2023 - a year ago
38 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
9/1/2023 - a year ago
39 - SOU EXTENSION 5 FILED
Type: EXT5
-
9/5/2023 - a year ago
40 - SOU EXTENSION 5 GRANTED
Type: EX5G
-
9/6/2023 - a year ago
41 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
1/18/2024 - a year ago
43 - USE AMENDMENT FILED
Type: IUAF
-
1/18/2024 - a year ago
42 - TEAS STATEMENT OF USE RECEIVED
Type: EISU
-
1/22/2024 - a year ago
44 - STATEMENT OF USE PROCESSING COMPLETE
Type: SUPC
-
2/20/2024 - 12 months ago
45 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Type: CNPR
-
2/21/2024 - 12 months ago
46 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Type: SUNA
-
3/26/2024 - 10 months ago
47 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
3/26/2024 - 10 months ago
48 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC